Related Experiment Videos
Developmental toxicity, reproductive toxicity, and neurotoxicity as regulatory endpoints
1US Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, Washington, DC 20460.
Abstract:
For decades, cancer has been the primary toxicological endpoint used in the assessment of hazard and risk. Regulatory decisions related to the manufacture, transport, and use of a chemical are often based solely on cancer data. Federal policy is now shifting toward more frequent evaluation and application of alternative endpoints of toxicity. Among the endpoints of particular current interest are developmental toxicity, reproductive toxicity, and neurotoxicity. Significant progress has been made in the development of standardized guidelines for testing chemicals for their potential effects on these endpoints. Corresponding guidelines for the assessment of risk on the basis of data on these endpoints are in various stages of development.
Insights
Cancer data has long dominated chemical risk assessment. Federal policy is shifting to include alternative toxicity endpoints like developmental, reproductive, and neurotoxicity, with developing guidelines for their evaluation.
Area of Science:
- Toxicology
- Chemical Risk Assessment
- Regulatory Science
Background:
- Historically, cancer has been the primary toxicological endpoint for chemical hazard and risk assessment.
- Regulatory decisions regarding chemical manufacturing, transport, and use have predominantly relied on cancer data.
- A significant policy shift is underway, prioritizing alternative toxicity endpoints.
Purpose of the Study:
- To highlight the evolving landscape of toxicological risk assessment.
- To introduce developmental toxicity, reproductive toxicity, and neurotoxicity as key alternative endpoints.
- To discuss the progress in developing standardized testing and risk assessment guidelines for these alternative endpoints.
Main Methods:
- Review of historical reliance on cancer endpoints in regulatory toxicology.
- Identification of emerging alternative toxicity endpoints gaining regulatory attention.
- Assessment of the status of standardized testing and risk assessment guideline development for these endpoints.
Main Results:
- Cancer data has been the cornerstone of chemical safety evaluations for decades.
- Developmental toxicity, reproductive toxicity, and neurotoxicity are now recognized as critical alternative endpoints.
- Standardized testing guidelines are advancing, while risk assessment guidelines are in earlier developmental stages.
Conclusions:
- The field of toxicology is moving beyond a sole reliance on cancer data for chemical risk assessment.
- Standardized methodologies are crucial for incorporating new toxicity endpoints into regulatory frameworks.
- Further development of risk assessment guidelines is necessary to fully implement these alternative endpoints in policy.